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In cocaine-dependent individuals, sleep is disturbed during cocaine use and abstinence, highlighting the importance of examining
the behavioral and homeostatic response to acute sleep loss in these individuals. The current study was designed to identify a
differential effect of sleep deprivation on brain bioenergetics, cognitive performance, and sleep between cocaine-dependent and
healthy control participants. 14 healthy control and 8 cocaine-dependent participants experienced consecutive nights of baseline,
totalsleepdeprivation,andrecoverysleepintheresearchlaboratory.Participantsunderwent
[31]Pmagneticresonancespectroscopy
(MRS) brain imaging, polysomnography, Continuous Performance Task, and Digit Symbol Substitution Task. Following recovery
sleep,
[31]P MRS scans revealed that cocaine-dependent participants exhibited elevated global brain 𝗽-NTP (direct measure of
adenosine triphosphate), 𝗼-NTP, and total NTP levels compared to those of healthy controls. Cocaine-dependent participants
performedworseontheContinuousPerformanceTaskandDigitSymbolSubstitutionTaskatbaselinecomparedtohealthycontrol
participants, but sleep deprivation did not worsen cognitive performance in either group. Enhancements of brain ATP levels in
cocaine dependent participants following recovery sleep may reflect a greater impact of sleep deprivation on sleep homeostasis,
whichmayhighlighttheimportanceofmonitoringsleepduringabstinenceandthepotentialinfluenceofsleeplossindrugrelapse.
1. Introduction
Comparedtohealthycontrolindividuals,cocaine-dependent
individualscommonlyexhibitdisturbedsleepduringcocaine
use and abstinence [1]. Following cocaine use, rapid eye
movement (REM) sleep decreases and slow wave sleep
increases [1], and while sleep parameters appear similar to
healthy control levels during early abstinence, sleep progres-
sively deteriorates as abstinence progresses [2, 3]. During
abstinence, cocaine-dependent men experience increased
sleep onset latency and wake after sleep onset, reduced
latency to REM, total sleep time, and sleep efficiency index,
and almost no slow wave sleep [4]. Studies have shown
t h a td u r i n ge a r l yc o c a i n ea b s t i n e n c e ,s u b j e c t i v er e p o r t so f
daytime sleepiness increase, but during late abstinence when
sleep architecture is at its worst, subjective sleepiness appears
to improve [2]. Enhancements in sleep disturbances with
prolonged cocaine abstinence and the effect this has on the2 The Scientific World Journal
likelihood of relapse to cocaine use indicate that monitoring
or improving sleep quality should be a primary clinical focus
as abstinence progresses [3].
A second problem facing cocaine dependent individuals
as abstinence progresses is a worsening of performance on
tasksassessingimpulsivity(IowaGamblingTask),immediate
and delayed memory, and sustained attention [5, 6]. These
deficits may be associated with sleep problems mentioned
above, as decrements in procedural learning tend to worsen
in parallel with worsening physiological measures of sleep
quality [7]. Collectively, these data demonstrate that alter-
ations in how cocaine-dependent individuals respond to
sleeplossmaybeassociatedwithadysregulationofthehome-
ostaticsleepprocesses.Sleeplossmayhavedifferentialeffects
oncocainedependentindividualsincomparisonwithhealthy
controlindividuals.Theidentificationofdifferentialeffectsof
sleep loss in cocaine-dependent individuals may be evident
in measures of neural correlates, sleep physiology/behavior,
and cognitive behavioral performance. Furthermore, these
measurablechangesmaybehighlyrelevanttotheacquisition
and perpetuation of chronic drug use and may have direct
effects on relapse potential during abstinence.
Sleep deprivation studies have revealed a disruption in
energy production and metabolism associated with sleep
loss, such that extended wakefulness serves as an energetic
challenge to the brain [8, 9]. In rodents, glycogen accumu-
lated during sleep is mobilized during waking and decreases
regionally during sleep deprivation [10]. Moreover, sleep
deprivation results in altered expression of mRNA coding
for regulators of glycogen synthesis and degradation [11,
12]. Although the effects on glycogen production are strain
dependent, sleep deprivation disrupts glycogen production
throughout the brain [13–15]. Beyond effects on glycogen,
sleep deprivation and energy metabolism have been linked
through adenosine triphosphate (ATP), a primary energy
currency among cells. Notably, the nucleoside adenosine,
primarily formed as a catabolic byproduct from ATP, is
central to the functionof the basal forebrain in the regulation
of recovery sleep after sleep deprivation, which links, albeit
indirectly, ATP metabolism and sleep homeostatic mecha-
nisms [16].
[31]P MRS provides a noninvasive in vivo method to
quantify the expression of high energy phosphates (𝗼-, 𝗽-,
and 𝗾-nucleoside triphosphates; NTPs), which are vital for
energy production in the brain. 𝗽-NTP is reflective of ATP,
while 𝗼-a n d𝗾-NTP are less specific and include ATP,
as well as adenosine di- and monophosphate. One study
using
[31]PM R Sf o u n dn oc h a n g ei nh i g he n e r g yp h o s -
phates in the frontal lobe the morning after a night of total
sleep deprivation [17]. However, a second study extended
these results by also assessing brain high-energy phosphate
metabolism after one night of recovery sleep. They also
found no changes after the night of total sleep deprivation,
but the morning after one recovery sleep night, total NTP,
𝗾-NTP,𝗽-NTP,andglycerophosphocholine(GPC;ameasure
of phospholipid degradation) were increased [18]. This study
also found corresponding increases in morning and evening
subjective sleepiness as well as the characteristic recovery
sleep-associated increases in the perceived depth of sleep,
slow wave sleep, and sleep efficiency index during the
recovery sleep night [18]. A more recent study examined
the effects of sleep deprivation in drug dependence on sleep
and brain bioenergetics [19]. In particular, the study found
in methadone-maintained opiate dependent subjects that
recovery sleep did not contain the characteristic increase in
sleep efficiency and that brain levels of ATP were increased
both after sleep deprivation and following recovery sleep.
The current study investigated effects of sleep depriva-
tion in cocaine-dependent individuals, examining changes
in brain bioenergetic metabolism, subjective and objective
sleep, and assessments of cognitive performance over the
course of one baseline night of sleep, one night of total
sleep deprivation, and one recovery sleep night.
[31]PM R S
brain imaging was used to assess the expression of brain
bioenergetics with particular interest in NTP measures of
ATP. Polysomnography assessed objective sleep, question-
naires assessed subjective sleep, and cognitive performance
was assessed with the Digit Symbol Substitution Task and
t h eCo n t i n u o u sP e r f o r m a n c eT a s k .Th e s ed a t aw e r ec o l l e c t e d
as a companion study to a study in methadone-maintained
individuals [19]. Based on these previous findings in a drug-
dependent population (methadone-maintainedparticipants)
and based upon findings in cocaine dependent individuals
indicating variable changes in the occurrence of sleep abnor-
malities between baseline active use and the progression of
abstinence, it was hypothesized that brain NTP levels would
increase after total sleep deprivation in both groups, and
thatincreasesinNTPwouldbegreaterincocaine-dependent
participants;thatcocaine-dependentparticipantswouldhave
disrupted sleep measurements following recovery sleep; that
cocaine-dependent individuals would exhibit poorer perfor-
mance on cognitive measures at baseline; and that sleep
deprivation would result in greater performance decrements
incocainedependentindividualscomparedtothatofhealthy
controls.
2. Methods
2.1. Participants. Participants were 14 healthy control adults
(50%female)and8nontreatmentseekingcocaine-dependent
adults (38% female). There were no significant differences
between healthy control and cocaine dependent groups on
sex (Table 1), but cocaine-dependent participants were older
(𝑃 < 0.05). Participants were recruited via newspaper,
radio,oronlineadvertisements.Afterinitialphonescreening,
participantsvisitedtheSleepResearchLaboratoryatMcLean
Hospital. Participants gave informed consent, underwent a
physical examination (electrocardiogram, complete blood
panel including a test of liver function), drug urine screen
( Q u i c k T o xD r u gS c r e e nD i p c a r d ,B r a n a nM e d i c a lC o r p o r a -
tion,Irvine,CA),andpregnancytest(StanbioQuPID,Studio
Laboratory, Boerne, Texas). On all study nights, participants
were again tested for drugs and pregnancy. Participants were
free of any current Axis I disorders (Structured Clinical
Interview for DSM-IV Disorders) [20], with the exception of
cocaine dependence for cocaine dependent participants.The Scientific World Journal 3
Table 1: The top panel shows demographic characteristics and
current drug use data of healthy control (HC), cocaine-dependent
(COC) participants. Demographics are presented as average ±
standard deviation or number of subjects.
HC COC
Age yr 34 (3.1) 44.5 (1.8)
Years of cocaine use — 16 (7.6)
Average weekly cocaine
use (days)
—
4.38 (1.9)
6 subjects predominantly
smoked cocaine
Average cigarettes per
day
— 2s m o k e r s
5.3 (0.4)
Cannabinoid — 1s u b j e c t
Opiates — 2s u b j e c t s
2.2. Sleep Deprivation Procedures. Participants took part in a
separate initial screening night of sleep with polysomnogra-
phy and full respiratory monitoring (respiratory flow, effort,
andoximetry)inordertoruleoutallprimarysleepdisorders
(including sleep apnea) and to allow the participants to
acclimatetosleepinginthesleepresearchcenter.Participants
then underwent three separate consecutive study nights in
the laboratory consisting of one baseline sleep night (8 hour
time in bed), one night of total sleep deprivation (sleep
deprivation: participants were awake for ≥36 consecutive
hours), and one recovery night (recovery sleep: 8 hour time
in bed). To ensure total wakefulness during all study nights
and during all active sleep deprivation periods, participants
remainedinanaturalsettingslaboratory(ahomelivingroom
laboratory environment) or the sleep laboratory bedroom,
where they were continuously monitored throughout exper-
imentation by laboratory research technicians.
2.3. Polysomnographic Recording. Electroencephalogram
(EEG), electrooculogram, electromyogram, and electrocar-
diograph were acquired using an Alice 4 Sleepware system
(Philips Respironics, Andover, MA). Electrode placement
was in accordance with standard polysomnography and
scored by standard scoring criteria [21]. Objective sleep
measures were defined as follows: wakefulness after sleep
onset—theamountofawakeaftersleeponset,sleepefficiency
index—the total time asleep as a proportion of the total time
in bed, total sleep time—total minutes of sleep after sleep
onset, slow wave sleep—the total minutes of slow wave sleep,
and total time spent in rapid eye movement (REM) sleep, in
minutes.
2.4. Cognitive Behavioral Testing. The Continuous Perfor-
mance Task [22] and the Digit Symbol Substitution Task
[23] were administered each study morning, and the Digit
SymbolSubstitutionTaskwasalsoadministeredpriortoeach
bedtime. To assess mood, participants were administered the
Profile of Mood States [24]; to assess subjective sleepiness,
participants were administered the Stanford Sleepiness Scale
[25] and a visual analog scale (anchors-sleepy, alert) in the
morning each study day and prior to bedtime.
2.5. Brain Magnetic Resonance Spectroscopy Imaging. MRS
imaging was performed on a 4Tesla whole-body (Varian/
U n i t y - I N O V A ;V a r i a n ,P a l oA l t o ,C A ,U S A )M Rs c a n n e r
operating at 170.31MHz for proton measurement and
68.95MHz for phosphorus measurement. A dual-frequency,
transverse electromagnetic design volume head coil tuned
to both proton and phosphorus frequencies was used for all
imagingandspectroscopyexperiments(BioengineeringInc.,
Minneapolis, MN, USA).
2.6. Proton MRS. High-contrast, T1-weighted sagittal images
of the entire brain were first acquired using a 3D magnet-
ization-preparedFLASHimagingsequenceallowingforclear
differentiation between grey and white matter, clearly delin-
eating between the different anatomical regions of interest.
Acquisitionparameters forthe sagittalimages were TE/TR =
6.2/11.4ms, field-of-view (FOV)=2 4 cm ×2 4cm, readout
duration =4 ms, receive bandwidth =± 3 2 kHz, in plane
matrix size = 256 × 256,i np l a n er e s o l u t i o n = 0.94mm,
readoutpoints = 512,axialplanematrixsize=1 6 ,axialplane
resolution = 2.5mm sagittal, and scan time =1minute, 15
seconds. High-resolution T1 weighted images were acquired
in the transverse plane with the same imaging sequence, but
32sliceswerecollectedof4mmnominalthickness,forascan
t i m eo f2m i n u t e s ,3 0s e c o n d s .
2.7. Phosphorus MRS. Phosphorus MRS was performed
with the phosphorus channel of the dual-tuned proton-
phosphorus head coil. Initially, eight control participants
were scanned using a 3D
[31]P MRS sequence. It was rec-
ognized that the drug dependent participants would be
either unable to complete the required >1-h scan duration
of the 3D
[31]P MRS scan due to anxiety or excessive
physical movement. To collect valuable scan data and to
maintaincomparabilityofscandata,atwo-dimensional(2D)
[31]P MRS sequence was used for the remaining fourteen
participants. Limiting the acquisition from a 2D slab allowed
for a scan duration of 9min compared to the 46-min 3D
sequence. The 2D-MRSI sequence was phase encoded over
a 6cm thick excitation slab placed in the exact same mid-
sagittal position as the 3 slices involved in the 3D sequence.
All other parameters were identical between the 2D- and
3D-
[31]P MRS protocols, including FOV (33cm ×3 3 cm),
TR (500ms), matrix (16 × 16,s p a r s es a m p l i n gs c h e m e
using the same SINC-lobe-modulated, weighted-average k-
space filter). Transmit/receive frequency was first centered
on the phosphocreatine (PCr) resonance, as measured with
a global free-induction decay (FID). The 2D-CSI sequence
used a reduced phase-encoding scheme [26], which allows
for inclusion of circularly bound, reduced-point, weighted k-
space acquisition, providing approximately 35% more signal-
to noise for a given scan time-and effective voxel volume
overconventionalmethods.Allviablevoxelsfromthreemid-
sagittal slices across the entire brain were analyzed from 3D
[31]P MRS data, which was essentially equivalent to the 2D
axial-plane consisting of 2cm ×2cm ×6cm voxels (slices
are effectively 2cm thick ×3s l i c e se q u a lt o6c mt h i c ks l a b
of interest). 2D-PSF (actual voxel signal distribution) and4 The Scientific World Journal
PCr
PME
PDE Pi
(a)
(b) (c)
𝗼-NTP
𝗽-NTP
𝗾-NTP
Figure 1: (a) Three representative axial brain slices illustrating voxel coverage for global whole brain
[31]P MRS assessment, (b) illustrating a
sagittal view of the voxelization of subcortical areas, and (c) a resultant
[31]P MRS imaging spectra indicating phosphorus-containing peaks.
signal to noise were analogous between 2D and 3D
[31]P
MRS acquisitions, and since the tip angle (32
∘)a n dT R
were the same between sequences, the resultant spectra were
virtually identical between sequences when tested back to
back on a healthy control subject in terms of metabolite T1-
weighting. Fundamental differences exist between the 2D-
and 3D-
[31]P MRS sequences that primarily emanate from
diminutive differences in the tip angle between sequences
( g l o b a ls q u a r ep u l s ef o r3 Dv e r s u ss e l e c t i v eS I N Cp u l s ef o r
2D), leading to minute T1-weighted differences in derived
peak areas. There is an inherent chemical-shift displacement
artifact using 2D
[31]P MRS, which could affect measures
of any off-resonance metabolites due to spatial shifts in slab
excitation. To rectify any potential influence, correction-
factors for each measured metabolite from a healthy control
participant were derived and for the 3D
[31]PM R Sd a t a .
The resultant metabolite measures were extremely in line
with the acquired 2D
[31]P MRS data, and there were no
significant differences for any of the MRS metabolites. All
in vivo CSI/image data were processed using Varian Nuclear
Magnetic Resonance software, Version 6.1b (Varian, Palo
Alto, CA, USA), and software developed on site. Prior to
Fast Fourier Transform reconstruction to spatially resolve
the CSI spectra, the collected k-space data was centered
in a 16 × 16 square matrix, and each time-domain FID
was zero filled out to 2048 complex points and left-shifted
five points removing residual bone/rigid membrane signal.
From the MRI images, the 2D-CSI data grid was shifted
in the 𝑥 and 𝑦 dimensions to position the sampling grid,
centeredinsidethebrainaccordingtoanatomicallandmarks.
The peak areas of the metabolites: phosphoethanolamine
(Pe), phosphocholine (PCh), inorganic phosphate (Pi), glyc-
erophosphoethanolamine(GPE)andglycerophosphocholine
(GPC), PCr, and three peaks for adenosine triphosphate
(𝗼-, 𝗾-, and 𝗽-NTP; Figure 1)w e r efi t t e dt oa nin vivo
spectralmodelusinganonlinear,iterative[27,28].Thefitting
routine was based on a Marquardt-Levenberg algorithm,
utilizingpriorspectralknowledgefortherelativeamplitudes,
linewidths, lineshapes, peak positions, and J-coupling con-
stants to model the in vivo
[31]P brain spectrum. The fitted
metabolite amplitudes were not T2-weighted since the fitting
algorithm backextrapolates to time zero. Fitted spectral peak
areas were expressed as a ratio to the total
[31]Ps i g n a lp e r
voxel.
2.8. Statistical Analysis. Demographic characteristics were
analyzedby𝑡-tests.Allotherdependentmeasuresweretested
using linear mixed model ANOVAs with sleep night and
treatment group as fixed factors. Because cocaine-dependent
participants were older than healthy controls (𝑃 = 0.02), age
w a si n c l u d e da sac o v a r i a t e .A l p h aw a ss e tt o𝑃 < 0.05 (two-
tailed)forallstatisticaltestsandBonferronicorrectionswere
used for multiple comparisons.
3. Results
3.1. Magnetic Resonance Spectroscopy. At baseline, there were
no differences between cocaine-dependent participants and
healthy controls for any metabolite. Importantly, there was
as l e e pn i g h t
∗group interaction for 𝗼-NTP (Figure 2(e);
𝐹[2,59] = 4.02; 𝑃 = 0.023), 𝗽-NTP (Figure 2(f), 𝐹[2,59] = 3.95;
𝑃 = 0.024), and total NTP (Figure 2(g); 𝐹[2,59] = 3.59;The Scientific World Journal 5
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Figure 2:
[31]P MRS global brain expression of inorganic phosphate (Pi; (a)), glycerophosphocholine (GPC; (b)), phosphocreatine (PCr;
(c)), 𝗾-nucleoside triphosphate (𝗾-NTP; (d)), 𝗼-NTP (e), 𝗽-NTP (f), and total NTP (g) in healthy control (control) and cocaine-dependent
(cocaine)participantsonthemorningsofbaseline(base;8hourtimeonbed),activelyprolongedwakefulstatefollowingsleepdeprived(SD),
and recovery (RE; 8 hour time on bed) sleep. Significance (Sig.):
∗sleep night 𝑃 < 0.05;
∗∗sleep night 𝑃 < 0.01;
∗∗∗sleep night 𝑃 < 0.001.
𝑃 = 0.035). Cocaine-dependent participants had higher
𝗼-NTP after recovery sleep than after sleep deprivation (𝑃=
0.008), higher 𝗽-NTP after recovery sleep than both baseline
(𝑃 = 0.016) and sleep deprivation (𝑃 = 0.001), and higher
total NTP after recovery sleep than both baseline (𝑃 = 0.043)
and sleep deprivation (𝑃 = 0.001). There was no significant
difference across the sleep deprivation paradigm for any
metabolites among healthy controls. There was an effect of
age on PCr (𝐹[1,59] = 4.63; 𝑃 = 0.036); however, there were
no significant effects of age for any NTP metabolite or GPC.
3.2. Polysomnography. For all polysomnography data, see
Table 2. There were no baseline differences, no effect of age,
and no sleep night
∗group interaction for any polysomno-
graphicvariable.Inbothgroupsonrecoverysleepnight,SOL
wasshorter(𝐹[1,39] = 4.75;𝑃 = 0.036),wakefulnessaftersleep6 The Scientific World Journal
Table 2: Polysomnographic assessments of sleep control versus all cocaine-dependent (COC) participants data are displayed as mean
(Standard Deviation).
Sig. Baseline Sig. Recovery Sig.
Control COC Control COC
Sleep onset latency (mins.) 23.3 (6.4) 34.3 (20.4) 10.5 (18.5) 4.6 (2.6) ∗
Waking after sleep onset (mins.) 54.9 (18.5) 66.5 (32.2) 14.7 (2.5) 33.0 (9.3) ∗
Sleep efficiency index 81.8 (4.3) 79.1 (5.2) 94.5 (1.2) 91.8 (1.8) ∗
Total sleep time (hrs.) 6.3 (0.3) 6.3 (0.4) 7.4 (0.2) 7.4 (0.1) ∗
Number of arousals ‡ 88.9 (10.1) 54.5 (6.5) 78.2 (8.9) 56.0 (7.2)
Arousal index 14.5 (2.0) 16.9 (7.8) 10.4 (1.3) 7.1 (1.0)
Stage 1 (mins.) 49.1 (8.6) 42.5 (3.4) 41.4 (8.0) 30.7 (5.1)
Stage 2 (mins.) 214.5 (12.7) 238.1 (19.1) 251.8 (11.5) 259.4 (7.8) ∗
Stage 3 (mins.) 27.7 (7.5) 16.7 (7.0) 32.7 (11.9) 18.3 (6.7)
Stage 4 (mins.) 8.5 (4.4) 7.2 (4.0) 16.9 (6.9) 12.9 (8.5)
REM (mins.) 79.4 (8.8) 74.3 (8.7) 101.3 (5.7) 121.8 (9.2) ∗
Slow wave sleep (mins.) 132.9 (34.6) 95.7 (36.5) 216.0 (50.6) 143.2 (57.6)
Significance (Sig.): ∗sleep night 𝑃 < 0.05; ‡group 𝑃 < 0.05.
onset was lower (𝐹[1,39] = 6.5; 𝑃 = 0.015), sleep efficiency
index was higher (𝐹[1,39] = 12.186; 𝑃 = 0.001), total sleep
time was longer (𝐹[1,39] = 14.0; 𝑃 = 0.001), Stage 2 was
longer (𝐹[1,37] = 4.54; 𝑃 = 0.04), and REM was longer
(𝐹[1,37] = 16.96; 𝑃 < 0.0001). Across both sleep nights,
cocainedependentparticipantshadfewerarousalscompared
to healthy control participants (𝐹[1,39] = 4.65; 𝑃 = 0.037).
3.3. Cognitive Performance. At baseline, cocaine-dependent
participants had slower reaction times (RTs) on correct
responses (hits) on the Continuous Performance Task
(Figure 3(d); 𝐹[1,18] = 34.64; 𝑃 < 0.001)a n dc o m p l e t e df e w e r
accurate substitutions on evening (Figure 3(e); 𝐹[1,29] = 4.63;
𝑃 = 0.045), and morning (Figure 3(f); 𝐹[1,18] = 6.82;
𝑃 = 0.018) Digit Symbol Substitution Task than healthy
controls. There was no effect of sleep night and no sleep
night
∗group interaction, but across all four days of assess-
ment, cocaine-dependent participants made more errors of
omission (Figure 3(a); 𝐹[1,56] = 4.46; 𝑃 = 0.039), had slower
hit RTs on the Continuous Performance Task (Figure 3(d);
𝐹[1,56] = 25.25; 𝑃 < 0.0001), and completed fewer accurate
substitutions on the evening (Figure 3(e); 𝐹[1,59] = 16.74;
𝑃 < 0.0001) and morning Digit Symbol Substitution Task
(Figure 3(f); 𝐹[1,56] = 19.57; 𝑃 < 0.0001). There was an
effect of age on the evening Digit Symbol Substitution Task
(𝐹[1,59] = 5.047; 𝑃 = 0.028).
3.4. Subjective Sleep and Mood. For all subjective sleep
and mood data see Table 3. At baseline, cocaine-dependent
participants reported lower sleepiness on the evening visual
analog scale (𝐹[1,19] = 10.79; 𝑃 = 0.004), higher restlessness
(𝐹[1,17] = 7.43; 𝑃 = 0.014), lower evening mood (𝐹[1,17] =
12.73; 𝑃 = 0.002), more difficulty waking (𝐹[1,16] =9 . 8 7 ;
𝑃 = 0.006), and lower physical ailments (𝐹[1,18] =8 . 3 4 ;
𝑃 = 0.01).Therewasalsoaneffectofageonratingsofrestless
(𝐹[1,17] = 7.94; 𝑃 = 0.012) regardless of treatment condition.
All participants reported less vigor in the evening prior
to recovery sleep than baseline nights (𝐹[2,56] =5 . 0 5 ; 𝑃=
0.01),morefatigueintheeveningpriortorecoverysleepthan
baseline (𝐹[2,56] = 22.73; 𝑃 < 0.0001) and sleep deprivation
(𝑃 < 0.0001), more fatigue on morning ratings after sleep
deprivation than baseline nights (𝐹[2,56] = 7.94; 𝑃 = 0.001);
and after sleep deprivation than recovery sleep nights (𝑃=
0.024) on the Profile of Mood States. All participants also
reportedbeingmoretiredontheeveningStanfordSleepiness
Scale prior to recovery sleep than baseline nights (𝐹[2,55] =
15.76; 𝑃 < 0.0001) and prior to recovery sleep than sleep
deprivation nights (𝑃 < 0.0001). Finally, all participants
reported being sleepier on the evening visual analog scale
after sleep deprivation than baseline nights (𝐹[2,58] = 16.31;
𝑃 = 0.015) after recovery sleep than baseline nights (𝑃=
0.02) and after recovery sleep than sleep deprivation nights
(𝑃 < 0.0001).
Across all sleep nights, cocaine-dependent participants
reported greater depression on evening ratings (𝐹[1,56] =
11.11; 𝑃 = 0.002), less evening vigor (𝐹[1,56] = 12.95;
𝑃 = 0.001), and more evening (𝐹[1,56] =7 . 7 7 ; 𝑃 = 0.007)
and morning (𝐹[1,56] = 4.11; 𝑃 = 0.047) tension on the
Profile of Mood States and lower evening (𝐹[1,38] = 35.02;
𝑃 < 0.0001) ratings of mood, less difficulty waking (𝐹[1,35] =
14.15; 𝑃 = 0.001) lower physical ailments (𝐹[1,37] =9 . 4 2 ; 𝑃=
0.004) on the PSI. Cocaine dependent participants reported
lower ratings of sleepiness on the evening visual analog scale
(𝐹[1,58] =4 . 5 4 ; 𝑃 = 0.037); however, pairwise comparisons
were not significant.
There was a sleep night
∗group interaction on ratings of
restless (𝐹[1,37] = 5.72; 𝑃 = 0.022), but pairwise comparisons
were not significant. There was also a sleep night
∗group
interaction on ratings of depth (𝐹[1,37] = 11.28; 𝑃 = 0.002),
with cocaine-dependent participants reporting less depth of
sleep after recovery sleep than sleep deprivation (𝑃 = 0.017)
and healthy controls reporting more depth of sleep after
recovery sleep than sleep deprivation (𝑃 = 0.029)o nt h eP S I .The Scientific World Journal 7
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Figure3:Differencesbetweenhealthycontrol(control)andcocaine-dependent(cocaine)participantsonContinuousPerformanceTaskand
for the Digit Symbol Substitution Task. The number of errors of omission (a) number, errors of commission (b), and the number of correct
responses (hits; (c)), the hit reaction time (RT; (d)) hit RT standard error ((d) inset) on the CPT. The number of correct substitutions on the
DSST as measured in the evening (e) and morning (f) of baseline (base; 8 hour time on bed), actively prolonged wakeful state following sleep
deprived (SD), and recovery (RE; 8 hour time on bed) sleep.
There was an effect of age on ratings of depth on the PSI
(𝐹[1,37] = 6.22; 𝑃 = 0.017) and on evening depression
(𝐹[1,56] = 5.05; 𝑃 = 0.029), evening vigor (𝐹[1,56] =7 . 8 4 ;
𝑃 = 0.007), and evening (𝐹[1,56] = 8.18; 𝑃 = 0.006)a n d
morning (𝐹[1,56] = 9.92; 𝑃 = 0.003) tension on the Profile
of Mood States.
4. Discussion
During an actively prolonged wakeful state following one
n i g h to ft o t a ls l e e pd e p r i v a t i o n ,t h e r ew e r en oc h a n g e si n
any metabolite in either study group. However, after one
recovery sleep night comprised of 8 hours time in bed,8 The Scientific World Journal
Table 3: Profile of Mood States (POMS), Post-Sleep Inventory (PSI), Stanford Sleepiness Scale (SSS), and Visual Analog Scale (VAS)
assessments of sleepiness and mood in control (control) versus cocaine-dependent (COC) participants data are displayed as mean (Standard
Deviation).
Sig. Baseline Sig. Sleep deprived Sig. Recovery Sig.
Control COC Control COC Control COC
POMS
Depression PM ‡ 3.4 (1.6) 11.6 (4.9) 2.6 (1.4) 3.3 (1.7) 2.5 (1.6) 7.0 (3.5)
Depression AM 3.4 (1.6) 3.3 (1.3) 3.3 (1.7) 5.0 (2.6) 2.5 (1.8) 4.1 (1.5)
Vigor PM ‡ 16.9 (2.2) 12.0 (2.2) 14.5 (2.2) 10.3 (2.3) 10.1 (2.5) 5.0 (1.5) ∗
Vigor AM 10.5 (2.3) 7.0 (2.0) 7.9 (2.1) 7.1 (1.7) 9.5 (2.3) 4.9 (2.5)
Fatigue PM 3.4 (0.8) 2.5 (1.2) 3.7 (1.0) 4.0 (1.3) 9.4 (1.7) 13.3 (1.8) ∗
Fatigue AM 4.1 (0.8) 3.5 (0.8) 9.1 (1.8) 9.0 (1.3) ∗ 5.8 (1.2) 4.9 (1.2)
Tension PM ‡ 5.3 (1.1) 7.0 (2.4) 5.5 (1.0) 5.9 (1.7) 5.5 (1.2) 8.8 (1.5)
Tension AM ‡ 4.3 (1.0) 4.3 (0.7) 4.7 (1.2) 6.5 (2.0) 4.2 (1.2) 4.3 (0.6)
PSI
Restless 6.2 (0.8) 8.1 (1.1) — — 8.4 (1.0) 5.3 (1.3) §
Depth 7.0 (0.8) 7.7 (0.7) — — 9.4 (1.0) 4.1 (0.5)
Mood PM ‡ 9.5 (0.7) 5.3 (0.9) — — 9.6 (0.7) 4.6 (0.6)
Mood AM 8.1 (0.7) 5.0 (0.9) — — 8.2 (0.8) 5.9 (1.2)
Rested 6.8 (0.8) 5.7 (1.0) — — 5.6 (0.8) 7.6 (1.3)
Difficulty waking 8.5 (0.9) 3.7 (0.6) — — 6.1 (0.8) 3.8 (0.5)
Physical ailments ‡ 8.9 (0.7) 5.3 (0.7) — — 8.4 (0.7) 6.0 (0.9)
Frequency of waking 6.9 (0.6) 5.9 (1.3) — — 9.6 (0.9) 5.6 (1.4)
SSS
Evening 3.7 (0.4) 4.0 (0.8) 2.6 (0.3) 2.9 (0.7) 5.2 (0.5) 6.0 (0.5) ∗
Morning 3.8 (0.4) 4.1 (0.5) 4.5 (0.5) 5.1 (0.4) 3.9 (0.4) 4.0 (0.7)
VAS
Evening 49.4 (6.7) 25.3 (7.8) 57.9 (7.3) 58.9 (7.5) ∗ 20.4 (4.4) 14.0 (8.6) ∗
Morning 50.4 (5.9) 41.1 (8.4) 29.0 (6.7) 23.9 (5.4) ∗ 41.9 (6.5) 33.6 (6.3)
Significance (Sig.):
∗sleep night 𝑃 < 0.05;
‡group 𝑃 < 0.05;
§sleep night
∗group interaction 𝑃 < 0.05.
𝗼-NTP, 𝗽-NTP, and total NTP significantly increased in
cocaine-dependent participants, but not in healthy controls.
These results partially fit with previous studies that found
no change in the high-energy phosphates or GPC after one
night of sleep deprivation [17, 18]. Dorsey et al. [18]d i d
report increases in 𝗽-NTP, 𝗾-NTP, total NTP, and GPC after
recovery sleep night in healthy controls. While the current
data does reflect an enhancement of NTPs including 𝗽-NTP,
the difference did not reach statistical significance during
post hoc comparisons. One possible explanation for this
difference is that the current study examined global whole
brain
[31]P MRS while Murashita et al. [17] examined only
t h ef r o n t a ll o b ea n dD o r s e ye ta l .[ 18] examined a 5cm
slice of brain centered on the basal ganglia and anterior
cingulate. The current results also partially fit with data
from a companion study obtained in methadone-maintained
participants showing increased 𝗽-NTP after one recovery
sleep night when compared to healthy controls [19]. This
indicates that increased energy (ATP) stores after a recovery
sleep night are not specific to cocaine-dependent users.
Although the elevated levels of 𝗽-NTP following recovery
sleep were common in both methadone-maintained and
cocaine dependent participants, the elevated 𝗽-NTP lev-
e l sw e r ei s o l a t e dt ot h em o r n i n gf o l l o w i n gr e c o v e r ys l e e p
in cocaine-dependent participants, while 𝗽-NTP elevations
were apparent in methadone-maintainedparticipantsduring
active sleep deprivation as well. The occurrence of changes
in 𝗽-NTP observed in methadone-maintained individuals
duringastateofactiveprolongedwakefulnessfollowingsleep
deprivation that continues on into the morning following
recovery sleep may be indicative of a greater disruption
to sleep homeostatic mechanisms in methadone-maintained
versus cocaine dependent individuals. Overall, these data
indicatethatelevated𝗽-NTPfollowingsleepdeprivationmay
reflect a greater susceptibility to the disruptive effect of sleep
loss on sleep homeostasis that is common to other forms of
substance dependence.
Polysomnography data from both healthy control and
cocaine-dependentparticipantsexhibitedthetypicalchanges
associated with recovery sleep, such as increased sleep effi-
ciency index and slow wave sleep during recovery sleep.
While Trksak et al. [19] found that methadone-maintained
participants did not exhibit the enhancements of total sleep
time and sleep efficiency index normally associated with
recovery sleep, in the current study cocaine-dependent sub-
jects did not appear to exhibit disrupted recovery sleep.
WhilethepolysomnographyresultsdidnotrevealstatisticallyThe Scientific World Journal 9
significant polysomnography sleep differences in cocaine-
dependentparticipants,thesleepfindingsaresimilartoother
studies that have reported a mismatch between objective
and subjective sleep [2, 18]. In this light, it is interesting
that subjective sleep and mood ratings obtained in the
current study were worse in cocaine-dependent participants
at baseline compared to healthy control participants.
Overall, cocaine-dependent participants performed sig-
nificantly worse on the Digit Symbol Substitution Task
assessmentofpsychomotorperformanceandtheContinuous
Performance Task assessment of selective attention and/or
impulsivity when compared to healthy control participants.
These findings are consistent with the majority of previ-
ous research demonstrating worse performance in cocaine
dependent participants than healthy controls [29], with the
largest effects on tests of attention (including the Digit
Symbol Substitution Task). Although there are limitations
to directly comparing these studies (differences abstinence
duration, amount and duration of cocaine use, concurrent
useofothersubstances)thesestudiesconsistentlyfinddecre-
ments in cognitive performance with cocaine dependence.
It was hypothesized that sleep deprivation would decrease
cognitiveperformanceincocainedependentparticipants,but
sleep deprivation did not significantly affect performance in
either group. The findings here fit with its companion study,
which also found poorer performance on these same tasks
in methadone-maintained participants when compared to
healthy controls, which was not worsened by sleep depriva-
tion [30]. These domains of cognitive function may be more
resilienttoacutesleeploss,butitispossiblethatthedemands
of a longer duration period of sleep deprivation could
intensify performance decrements in these drug-dependent
populations.
A possible limitation to this study is the older age of
cocaine dependent participants. A previous study between
olderandyoungercocaine-dependentandolderandyounger
healthycontrolpopulationsfoundthatolderusersperformed
more poorly than controls and younger users on the Digit
Span Forward Task, and older users performed more poorly
thanyoungerusersontheTrailMakingTask-A[31].However,
there were no other age
∗group interactions in that study.
To address the age difference between groups in the current
study, we included age as a covariate in all of the analyses
and found an effect of age only on the evening Digit Symbol
Substitution Task, brain expression of PCr, and ratings of
depth of sleep, vigor, and tension. A second limitation of
the current study may be the limited sample size particularly
in the cocaine dependent group. As our primary hypothesis
was related to changes in brain bioenergetics following sleep
deprivation in cocaine dependent participants, upon interim
analysis it became clear that we had obtained robust and
significant effects with the current sample size and we ceased
data collection. Additionally, a potential limitation of the
study may be that MRS imaging was collected from large
areas of the brain including temporal, parietal, and frontal
cortical regions. In this voxel matrix, there is an inherent
bias for occipital and frontal locations, and it includes dien-
c e p h a l i cr e g i o n ss u c ha st h a l a m i ca n dh y p o t h a l a m i cr e g i o n s ,
a n dt h u st h e r ec o u l db ed i s p a r a t el e v e l so fb i o e n e r g e t i c s
distributed throughout these regions.
5. Conclusions
Collectively, the findings indicate that although changes
during active sleep deprivation and following recovery sleep
were not identified in cognitive performance data, there
were robust changes in brain bioenergetics in cocaine-
dependent participants, most profoundly in measures of
NTP levels following recovery sleep. One explanation is
that the brain increases ATP energy production to serve
a compensatory capacity in order to allow the individual
to maintain cognitive function and capacity during sleep
deprivation. In this context, mechanisms that begin during
prolonged wakefulness to assure adequate availability of ATP
m a yf a i lt od o w n r e g u l a t ea p p r o p r i a t e l ya ft e rr e c o v e r ys l e e p
in cocaine-dependent individuals. Another explanation may
be that sleep deprivation results in a mode of metabolic
conservationwhere energy utilizationis reduced to maintain
functionduringprolongedperiodsofwakefulness.Whilethe
functionalrelevanceofchangesinbrainbioenergeticsduring
and following sleep deprivation has yet to be fully elucidated,
these sleep deprivation-induced fluctuations in brain ATP
appear to be a prominent aspect of brain changes modulated
by sleep homeostatic processes. The enhancements in ATP
levels presently observed appear to be at the expense of
PCr levels, which are indicative of a change in the creatine
kinase equilibrium, potentially indicating that the brain is
working harder in a sleep deprived state. The enhanced ATP
levels in cocaine-dependent participants in the current study
were focused in the morning following recovery sleep, while
enhanced brain ATP levels were markedly more pronounced
both following recovery sleep and during active sleep depri-
vation in methadone-maintainedparticipants in Trksak et al.
[19]. This may indicate that although both drug-dependent
groups exhibit an altered response to sleep deprivation, the
impactofacutesleeplossonhomeostaticmechanismsmaybe
greater in methadone-maintained individuals than cocaine-
dependent individuals. Collectively, these changes in brain
ATP levels following recovery sleep in cocaine-dependent
participants when compared to healthy control participants
arelikelyindica tiveofagrea terim pactofsleepdepriva tionto
sleephomeostaticmechanismsthatmayreflectanunderlying
metabolic vulnerability to sleep loss in this population. This
may have direct implications for daily function and decision-
making and furthermore have an influence on the likelihood
of relapse to cocaine use during abstinence. These findings
highlight the potential clinical importance of monitoring or
improving sleep quality as abstinence progresses [3].
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